OTTAWA (Reuters) – Canada said Tuesday that the AstraZeneca COVID-19 vaccine is safe and will be recommended for use despite criticism from U.S. health officials about the drug dealer’s investigation into the effectiveness of the shot, officials said Cheers.
“The message is that the effectiveness and safety of the vaccine has been demonstrated,” Canada Health chief executive Marc Berthiaume told reporters. “It is in the interests of Canadians to block COVID-19.”
Delivery of coronavirus vaccines is on the rise in Canada, with approximately 2 million doses of the Pfizer Inc and Moderna Inc vaccines coming in this week. The United States has said it is sharing 1.5 million doses of the AstraZeneca vaccine with Canada as early as this week.
The U.S. National Institute for Allergies and Infectious Diseases said Monday that the board responsible for ensuring AstraZeneca’s latest test says the company may have provided an incomplete view of effectiveness. the picture. The company has since stated that they will publish the latest results here from their latest test within 48 hours.
“We will look at the complete data package (from the US) sometime in April, and evaluate and communicate the results,” said Supriya Sharma, chief medical consultant at Health Canada, federal ministry of health. “The bottom line is: that doesn’t change recommendations on the AstraZeneca vaccine at this point.”
There will be a delay of a day or two of delivery of the Moderna vaccines this week, Alberta ‘s Chief Medical Officer said on Twitter on Tuesday, adding that it will not affect tickets for pictures.
Also Tuesday, Canada said it would give C $ 23.7 million ($ 18.9 million) to the province of Ontario to open more free isolation sites for those who catch the virus and need a place for quarantine as things go. crossing the third wave.
Canada has recorded about 940,000 viral infections and more than 22,700 deaths from COVID-19.
($ 1 = 1.2561 Canadian dollars)
Reciting with Steve Scherer; edited by Grant McCool